It is now assumed that proper functioning of the thyroid gland (TG), beside iodine, requires also a number of elements, including selenium, iron, zinc, copper, and calcium. In many cases, only an adequate supply of one of these microelements (e.g. iodine) may reveal symptoms resulting from deficits of other microelements (e.g. iron or selenium). Selenium is accounted to the trace elements of key importance for homeostasis of the human system, in particular, for the proper functioning of the immune system and the TG. Results of epidemiological studies have demonstrated that selenium deficit may affect as many as one billion people in many countries all over the world. A proper sequence of particular supplementations is also worth emphasising for the significant correlations among the supplemented microelements. For example, it has been demonstrated that an excessive supplementation of selenium may enhance the effects of iodine deficit in endemic regions, while proper supplementation of selenium in studied animals may alleviate the consequences of iodine excess, preventing destructive-inflammatory lesions in the TG. This paper is a summary of the current knowledge on the role of selenium in the functionality of the TG. 
Introduction
Selenium is accounted to the trace elements of key importance for homeostasis of the human system, in particular, for the proper functioning of the immune system [1, 2] . Results of epidemiological studies have demonstrated that selenium deficit may affect as many as one billion people in many countries all over the world [3] .
Selenium doses and sources
Following the recommendations of the World Health Organisation (WHO), supplementation of this microelement should not exceed 70 µg/day, while its daily intake above 400-700 µg may exert toxic effects [4] . Following the guidelines developed by the Food and Nutrition Board of the National Academy of Science, men should consume 40-70 µg and women 45-55 µg (60-70 µg during gestation and lactation periods) daily [5, 6] . According to population studies, the mean daily intake of selenium at European countries is 20-70 µg [1, 5, [7] [8] [9] and 20-59 µg in Poland [10, 11] . In turn, following the 30-day observation of other researchers, a typical diet of an average American provides from 90 to 168 µg of this microelement daily [12] . It is estimated that, in some regions of China, selenium consumption reaches the level of 5 mg/day [10, 13] . In order to ensure an adequately broad safety margin, in some sources, we may come across the term reference selenium dose (RSD). According to Patterson and Levander the RSD is 350 µg/day, which corresponds to the supplementation level of approximately 5 µg/kg of human body weight. According to the authors' assumption, the daily dose of 150 µg should be delivered with food, while the remaining 200 µg may be provided by supplements [14] .
Thus, considering the application of selenium supplementation, one should be aware of its narrow therapeutic index and of the possibility of adverse effects, not only when diet supplements are used but concentrations of P selenoprotein were obtained at serum selenium levels from 110 to 125 µg/L [25] . In the literature, one may come across various reference ranges of selenium concentration in serum, depending on the geographic region, the country, as well as the ethnic group, which is related to diet.
The issue of selenium deficit
The effects of selenium deficit may be observed in the geographic regions with low selenium soils, such as Siberia and a major part of China [16, 26, 27] . The symptoms of selenium deficit concern many organs and systems and are manifested by decreased activities, as well as by impaired functions and structures that are associated with this microelement, i.e. the so-called selenoproteins [28] . The adverse effects caused by selenium deficit and most frequently described in literature include dilated cardiomyopathy (Keshan disease) and endemic osteoarthropathy (Kashin-Beck disease) [28] [29] [30] .
The incidence of Keshan disease is highest in women of reproductive age and in children aged up to 10 years [30] . In turn, Kashin-Beck disease is characterised by changes that resemble rheumatoid arthritis, including shortening of fingers and toes and growing disturbances. Enhanced oxidative processes bring about lesions and necrosis of cartilages and cause bone deformations. The disease affects most often children aged up to 13 years [7, 29] . Iodine deficit contributes to the occurrence/ /enhancement of Kashin-Beck disease symptoms [29, 31] .
The following other significant effects of selenium deficit are worth mentioning: heart failure, arrhythmia, strokes, sudden infant death syndrome, infertility in men, prostate cancer, nephropathy, and exacerbation of symptoms of diseases, both associated with the immune system and autoimmunological; among others, thyroid disease [26, [32] [33] [34] .
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haematopoiesis disorders, hair loss, infertility, rash, nail fractures, and an unpleasant (resembling garlic) mouth odour, as well as various neurological disorders [7, 27, 37] . The negative consequences of selenium excess on the endocrine system should also be mentioned, including an impaired synthesis of thyroid hormones (TH), growth hormone, and insulin-like growth factor-1 (IGF-1) [7] . It has also been demonstrated that its excessive supplementation may increase the risk for diabetes mellitus of type 2 [38] . Moreover, inhalation of selenium compounds may contribute to the occurrence of chemical bronchitis and pneumonia (even pulmonary oedema), eye irritation, and headaches. The clinical data on doses that may cause adverse effects are rather inconclusive. It was shown in a study of the Chinese population that an increased incidence of selenosis is associated with doses of this microelement above 850 µg/day [26] . In turn, regarding patients with rheumatoid arthritis, daily supplementation with 600 µg of selenium from yeasts reduced arthritic pain but without any symptoms of intoxication with selenium [39] . In another study, patients receiving a daily dose of selenium of 700 µg tolerated it very well [40] . In the opinion of many authors, the major benefits from selenium supplementation are observed in persons with a decreased supplementation rate of this microelement. In other cases, one should take under consideration an increased risk of the occurrence of metabolic disorders [38, 41] .
How selenium works
As already mentioned, selenium atoms are part of the so-called selenoproteins and antioxidative enzymes, including, among others: glutathione peroxidases (GPs), thioredoxin reductases (TRRs), iodothyronine deiodinases (DIOs), selenoprotein P1 (SPP1), and selenoprotein W. GP was the first described selenoprotein; however, eight isoforms of the enzyme have so far been identified, depending on their structure and localisation [42] . The main task of GP is the protection of lipid membranes against oxidative stress. They catalyse the reactions of hydrogen peroxide (H 2 O 2 ) reduction and of organic peroxide (ROOH) reduction, with production of selenous acid, as an intermediate product, or of some appropriate alcohols [33] .
Three types of DIOs are distinguished. They play a key role in the activation of the other forms of TH to the most active triiodothyronine (T3) (type 1 and 2) and, in addition, in the inactivation of thyroxin and T3 (type 3) [43] [44] [45] [46] . The above-mentioned group of enzymes plays then a key role in the proper functioning of the TG, as well as in its development [47] . In the case of selenium deficit, iodine metabolism is impaired, which supports various disorders in the synthesis of TH. It may have some impact on the clinical state and the general wellbeing of affected patients [34] .
TRRs are biochemically responsible for the reaction of oxidised thioredoxin reduction. The enzymes of this group constitute an electron donor for other important oxidoreductive enzymes, e.g. ribonucleotide reductase and thioredoxin peroxidase. The thioredoxins alone reveal properties of apoptosis inhibitors, growth factors, and hydroperoxidase reducers. In addition, TRRs may reduce oxidised glutathione, dehydroascorbic acid, vitamin K, lipid peroxides, and hydrogen peroxide [48] .
SPP1, besides its role of selenium storage site and transporter along the system, acts as a heavy metal chelator. It creates non-toxic complexes with them and may also exert anti-tumour activity [49, 50] . Selenoprotein W is responsible for metabolism of the muscular system, and N for muscle tissue development [3, 51] . It has been shown that certain mutations in the gene for selenoprotein N can cause multiminicore myopathy [51] . Other selenoproteins (S, M) were also identified [47, 52, 53], but their role is not yet well understood.
It mentioned earlier, selenium can control the functions of the immune system [1, 2] . It has been demonstrated that the above-mentioned element can stimulate the synthesis of antibodies, especially of IgG and IgM, and activate lymphocytes T and macrophages [38] . It has also been proven that selenium-containing compounds may suppress the transformation of HIV infection to fully symptomatic AIDS [54] . Selenium also exerts antiviral and antibacterial effects and inhibits the progression of various forms of viral hepatitis. It may also prevent infections with RNAs of certain viruses, among others, of the Ebola virus [1, 2, 55, 56] .
The postulated anti-tumour properties of selenium are largely based on its already mentioned antioxidative properties. The advantageous effects of selenium on the activation of NK lymphocytes should be mentioned as well [50] . Thus far, the positive properties of selenium have been described in the context of colonic, prostatic, and pulmonary carcinoma [52] . There are also reports on the role of selenium in the conductivity of impulses in the central nervous system (CNS) [1, 57] . Moreover, the above-mentioned microelement may prevent diabetes mellitus, cardiovascular diseases, and infertility [26, 32] .
Selenium and the thyroid gland
Thyroid diseases are considered to be among the most frequent medical conditions in general, and, decisively, they are the most frequent problems of endocrine character with which patients visit their GPs [58-60], while L-thyroxin is in the top ten of the most frequently prescribed and taken medicinal products [58, 61] .
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It is now assumed that proper functioning of the TG, besides iodine, also requires a number of elements, including selenium, iron, zinc, copper, and calcium [44, [62] [63] [64] [65] [66] [67] . In many cases, only an adequate supply of one of these microelements (e.g. iodine) can reveal symptoms resulting from deficits of other microelements (e.g. iron or selenium) [62, 63, 66] . A proper sequence of particular supplementations is also worth emphasising for the significant correlations among the supplemented microelements. For example, it has been demonstrated that excessive supplementation of selenium may enhance the effects of iodine deficit in endemic regions, while proper supplementation of selenium in studied animals may alleviated the consequences of iodine excess, preventing destructive-inflammatory lesions in the TG [44, [68] [69] [70] [71] [72] . The TG, similarly to the testes and the brain, and unlike other organs in the human body, is characterised by high selenium content, despite its deficit in the system [44] . Studies carried out in patients with mutations of selenocysteine insertion sequence (SECIS) binding protein 2, may provide good proof of the significant role of selenium on the thyroid metabolism. This protein plays a significant role in the synthesis of selenoproteins. It has been observed that various mutations of the gene for the above-mentioned protein are, among others, responsible for the characteristic hormonal configuration: increased concentrations of TSH and FT4 and a decreased concentration of FT3 plus sensorineural hearing loss. Moreover, other, more characteristic features may occur, such as impaired development of the osseous system, myopathy, disturbances in CNS development, regarding the motor abilities, hypersensitivity to UV, and enhanced insulin sensitivity [73] [74] [75] [76] .
As already mentioned, all the DIOs, as well as other proteins, including GPs and TRRs, contain selenium atoms. A high activity of these enzymes has been demonstrated in the thyroid tissue; however, in order to maintain iodine metabolism, catalysed by deiodinases, and at an appropriate level, low activity of these enzymes will be enough, much lower than of other selenoproteins in the pathways of the metabolic turnover of proteins, fats, and amino acids [34, 77, 78] . Therefore, neither the concentration of selenium nor the concentrations of selenium-containing proteins directly influence the selenium content in the thyroid and the activity of selenoproteins contained in the TG [69, 79] . There is no data in the available literature concerning the measurable parameters that would unequivocally and reliably reflect thyroid supplementation with selenium.
A number of significant clinical data on the role of selenium supplementation in TG homeostasis were provided by studies carried out in Central Africa during the 1980s. Symptoms of cretinism with myxoedema were observed in the population living within that area, including mental retardation, growth suppression, and impaired puberty. The studies further confirmed that all those conditions had been associated with iodine and selenium deficits on one hand, and with the consumption of large quantities of foods containing goitrogens on the other [44, 80] . Negative additive effects, resulting from deficits of either microelement, have also been confirmed by the results of studies on animals [80, 81] . Most probably, it is the transforming growth factor β (TGF β) which is responsible for thyroid tissue damage and fibrosis resulting from selenium deficits. TGF β mediates the stimulation of destruction, caused by oxidative stress and initiated by high TSH concentrations [71] . In turn, appropriate selenium supplementation protects from the described processes, even when iodine supplementation is high, following its long-term deficit [68, 71, 72, 80] . According to the results of studies carried out in Zair, selenium supplementation without previous compensation of iodine deficit may deteriorate the patient's thyroid functioning; therefore, previous iodine assays and supplementation, if necessary, are required [80] . An increased activity of deiodinases and an increased metabolism of TH, with their enhanced deiodination and iodine loss with urine, are assumed to be the mechanism of this phenomenon [44]. The above described clinical situation concerned a severe deficit of both microelements.
There are many hypotheses concerning the protective role of selenium in thyroid diseases. At present, it is assumed that proper selenium supplementation may [41] : 1. decrease the expression of HLA-DR antigens on thyrocyte surface, 2. cause a decrease in the concentrations of antithyroid antigen antibodies, 3. control the lymphocyte B-dependent immunological response, 4. inhibit the production of proinflammatory cytokines, 5. reduce the synthesis of leukotrienes and prostaglandins, 6. protect the thyroid against oxidative stress, 7. optimise the synthesis and transport of TH via induction of selenoprotein synthesis (among others, p15 and S) [82] [83] [84] .
In recent years, several selenium-containing analogues of thyrostatics have been produced, as well as of compounds that imitate the action mode of selenoproteins [85] [86] [87] [88] . The anti-thyroid drugs that are currently available on the market may cause a number of unpleasant adverse effects [89] ; therefore, a possibility of the synergistic effect of action on the suppression of not only the biosynthesis but also of the activation of THor their activation alone -may lead to a new, valuable therapeutic option for patients with hyperthyroidism
of different aetiologies and will be better tolerated than already available anti-thyroid medications [90] .
One of the first interventional studies in which the supplementation of various vitamins and microelements was applied, demonstrated that too small supplementation of selenium influenced the growth of the TG only in women [91] . Analogous results were obtained when a Danish population was examined, also finding out a reverse correlation between selenium concentrations and the number of focal changes in the TG [92] . Changes in serum selenium levels were also observed in other benign and malignant diseases of the TG [93] . As is common knowledge, the incidence of thyroid diseases is higher in women than in men [94] ; however, no causes of this phenomenon have yet been adequately understood. An influence of female sex hormones is postulated, as well as the protective activity of factors that depend on the presence of chromosome Y or on the different mechanisms by which the immune systems function in both sexes. It is also worth emphasising that the advantageous effects of selenium in cases of thyroid diseases have been demonstrated in women, while in men it has been shown in other organs [83, [95] [96] [97] [98] .
Data that confirm the hypothesis of the beneficial selenium supplementation effects in the case of thyroid cancer are rather scarce and apply mainly to its papillary form [99] [100] [101] . In many studies on animal models, as well as in epidemiological and interventional surveys, beneficial effects were confirmed of normal or even increased serum selenium concentrations on the initiation, progression, and even metastases of various cancer types but not of thyroid cancer [50, 102] . The relationship between selenium supplementation and the incidence of thyroid cancer has been verified in many clinical studies (Table I) ; however, it has not been unequivocally confirmed, especially in the Polish population [103] [104] [105] [106] [107] [108] [109] [110] [111] . The access to mainly retrospective data, the relatively small groups of patients, and the short observation periods, as well as only single assays of selenium concentration levels, were all significant limitations in the performed studies. One should also consider the fact that low selenium concentrations may be not a cause but a result of some concomitant systemic diseases, also neoplastic, even in the effects of sustained chronic inflammation, which may impair the production of SPP1 in the liver, which, as is known, reflects the body's supply with this microelement [112] [113] [114] [115] .
Selenium in autoimmune diseases of the thyroid gland
It is known that selenium affects the process of differentiation of T lymphocytes in such a way that its increasing supplementation may induce increased production of regulatory T lymphocytes and a decrease of the synthesis of anti-thyroid antigen antibodies and of lymphocyte infiltrations [116] , while its deficit may enhance the activity of Th2 lymphocytes [117] . In addition, it has been demonstrated on an animal model of chronic autoimmune thyroiditis (CAT) that selenium supplementation suppresses the Th1-dependent immune responses, thus inhibiting the inflammatory response and the occurrence of destructive lesions in the TG [118] . Moreover, in blood from healthy males, supplemented with a selenium-containing agent, a lower number of NK lymphocytes was observed [119] . The presented results suggest beneficial effects of selenium on the autoimmune diseases of the TG [83, 120] . In women at risk of postpartum thyroiditis, proper supplementation of the microelement may provide a prophylactic effect against the disease, although the data from clinical studies still require additional confirmation [121, 122] .
In addition, lower selenium concentrations were found in serum from patients with Graves' disease and with hypothyroidism in the course of CAT. However, the results of studies on the correlation between the concentrations of anti-TPO, anti-TG, and anti-TSHR antibodies and selenium supplementation rates are much less conclusive [123] . In many interventional studies, no relationship was found between the time of selenium intake and selenium dose on one hand, and changes in the concentrations of TSH and TH on the other; however, most of the studies were not carried out in cases of severe selenium deficit [44, 98, 124, 125] . Therefore, the results of those studies may have also been a consequence of good mechanisms of supplementation with selenium of the TG and of the anterior pituitary, despite maintained systemic selenium deficit.
A number of prospective studies have also been run to evaluate the severity of symptoms resulting from identified autoimmune thyroid disease, as well as to assess the quality of patient life and TH production rates and concentration levels. The results of meta-analyses of the studies are often divergent and non-unequivocal. In one of the meta-analyses [123] its authors evaluated the results of four clinical studies assessing the effect of supplementation with sodium selenate (IV) and with selenomethionine in a daily dose of 200 µg on various end-points in patients with diagnosed CAT. In each of the three studies, where selenomethionine had been used, a significant reduction was found in the concentration of anti-TPO antibodies. That effect was not significant in the population, which had been supplemented with selenate; however, improved quality of patient life was reported by patients from that population [123] . Despite all the encouraging beneficial and supplementation results, the authors of the above described statistical analysis recommend a precaution- 
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.). Short characteristics of the most important clinical trials, concerning the relationship between selenium and thyroid cancer
ary approach to the issue for the high heterogeneity and the relatively small numbers of the studied populations, different observation time periods (7.5 months on average), and a high risk of bias [123] . While studying the effects of selenium on patients with Hashimoto's disease, the authors of another meta-analysis [120] also found a significant decrease in the concentration of anti-TPO antibodies and some improvement in the quality of life of those patients already after three months of supplementation. Moreover, those authors observed a correlation between the strength of the response to supplementation and the initial concentrations of anti-TPO antibodies. Nine studies and a total of 787 patients were taken into account in another meta-analysis. All the patients received 200 µg of selenate or selenomethionine and, possibly, additional doses of L-thyroxin (in four clinical studies) and methimazole (in one clinical study). In a clear majority the patients were diagnosed with CAT, while in one study the efficacy of the therapy was evaluated in patients with diffuse toxic goitre. A six-month supplementation brought about a significant drop in the concentrations of anti-TPO antibodies. In turn, the results obtained after 12 months of therapy demonstrated a significant drop in the levels of anti-TG and also anti-TPO antibodies. In addition, based on the data from two studies, the beneficial effect of selenium supplementation was confirmed regarding the mood of the patients [126] . Brief characteristics of the most important prospective clinical studies [98, 122, [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] concerning the efficacy of supplementation with selenium in benign thyroid diseases, in particular autoimmune diseases, are presented in Table II .
The role of selenium in thyroid gland pathophysiology -significantly lower fT3 and fT4 and higher TSH after 2 months of therapy -significantly higher aTSHR level after 6-month supplementation (assayed at follow-up visit)
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-significantly higher percent of aTSHR normalisation after 6 months (19% vs. 0%)
-significantly higher chance to achieve remission in selenium taking patients CAT -chronic autoimmune thyroiditis; RCS -randomised clinical study; NRCS -non-randomised clinical study -open label; GP1 -glutathione peroxidase 1; SPP -P selenoprotein Table II (cont.) . Main characteristics of major clinical studies concerning the relationship between selenium and benign thyroid diseases after 12 months, already after selenium withdrawal, were analogous to those obtained before [145] . The results, as presented above, have contributed to the inclusion of selenium supplementation in the recommendations of European Group on Graves' orbitopathy (EUGOGO), issued in 2016, according to which, in benign forms of short-term thyroid orbitopathy, the use of sodium selenate is recommended twice daily in dose of 100 µg for six months [146] , although its use was already encouraged before that [147] . Two interesting clinical trials are currently underway [148, 149] , the results of which may bring us closer to a more conclusive answer to the question of whether supplementation with selenium significantly influences the state of patients with Graves' disease [148] and the quality of life of patients with CAT [149] . Selenium plays a significant role in the maintenance of homeostasis of the human body. Selenoproteins protect the body against damage exerted by oxidative stress, including lesions in the TG, and are responsible for its physiological activity and adequate hormonal production. The issue of selenium supplementation for primary and secondary prophylactic purposes, regarding various structural and functional disorders of the TG, remains an open question and requires further studies. Taking into account the data from the presented clinical studies, one should consider the application of selenium supplementation in autoimmune diseases of the TG, including the widespread Hashimoto disease. Patients who are in the population with selenium deficit may especially benefit, as well as persons in whom selenium deficit is confirmed by selenium concentration assay in plasma. One should then consider the cost-effectiveness of such an approach and the possible implementation of such studies into diagnostic algorithms. However, the rather narrow therapeutic
index of selenium should be taken into account, as well as the risk associated with acute and chronic overdose, in particular, the increased risk for development of diabetes mellitus type 2. In consideration of the increased demands for selenium in pregnancy, the benefits should also be considered, which could be achieved as a result of selenium supplementation in pregnant women and, possibly, appropriate recommendations should be defined, similar as those formulated for iodine [150] . At present, a six-month supplementation with 200 µg of selenium is recommended in mild forms of shortterm thyroid ophthalmopathy, taking into account its measurable clinical benefits.
The role of selenium in thyroid gland pathophysiology Michał Stuss et al. 
Wstęp
Selen jest zaliczany do pierwiastków śladowych mają-cych kluczowe znaczenie dla utrzymania homeostazy organizmu ludzkiego, szczególnie dla prawidłowego funkcjonowania układu odpornościowego [1, 2] . Wyniki badań epidemiologicznych wykazały, że niedobór selenu może dotyczyć aż 1 miliarda ludzi na całym świecie i wielu krajów [3] .
Dawki selenu i źródła
Według zaleceń Światowej Organizacji Zdrowia (WHO, ang. World Health Organization) podaż tego mikroelementu nie powinna przekraczać 70 µg/dobę, a dzienne spożycie powyżej 400-700 µg może wywierać działanie toksyczne [4] . Zgodnie z zaleceniami opublikowanymi przez Food and Nutrition Board of the National Academy of Science mężczyźni powinni spożywać 40-70 µg a kobiety 45-55 µg (w ciąży i w okresie karmienia 60-70 µg) selenu dziennie [5, 6] . Jak wykazały badania populacyjne średnie dobowe spożycie selenu w krajach europejskich wynosi 20-70 µg/dobę [1, 5, [7] [8] [9] , a w Polsce 20-59 µg dziennie [10, 11] . Z kolei według 30-dniowej obserwacji innych badaczy typowa dieta przeciętnego Amerykanina dostarcza codziennie od 90 do 168 µg tego pierwiastka [12] . W niektórych regionach Chin szacuje się, że spożycie selenu sięga wartości nawet 5 mg/dobę [10, 13] . Aby zapewnić odpowiednio szeroki margines bezpieczeństwa, w niektórych źródłach możemy spotkać się z pojęciem dawki referencyjnej selenu (ang. Reference Dose; RfD), która według Pattersona i Levandera wynosi 350 µg dziennie, co odpowiada podaży około 5 µg/kg masy ciała człowieka. Zgodnie z założeniem autorów 150 µg selenu dziennie powinien zapewnić pokarm a pozostałe 200 µg suplementy [14] . Rozważając zatem zastosowanie suplementacji selenu należy mieć świadomość jego wąskiego indeksu terapeutycznego i możliwości wystąpienia nieprzyjemnych działań niepożądanych, nie tylko w przypadku stosowania suplementów diety, ale także pokarmów w niego obfitujących [15] . Wykazano, że spożycie dużej ilości owoców pewnych roślin, między innymi z gatunku Lecythis ollaria może powodować u ludzi wypadanie 
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Warto również podkreślić negatywny wpływ nadmiaru selenu na układ wewnątrzwydzielniczy, obejmujący upośledzenie syntezy hormonów tarczycy (HT) i hormonu wzrostu oraz pierwszego insulinopodobnego czynnika wzrostu (ang. Insulin-like Growth Factor-1; IGF-1) [7] . Wykazano także, że jego nadmierna podaż może zwiększać ryzyko wystąpienia cukrzycy typu 2 [38] . Ponadto wdychanie związków selenu może przyczyniać się do wystąpienia chemicznego zapalenia oskrzeli i płuc (nawet obrzęku płuc), podrażnienia oczu oraz bólów głowy. Dane kliniczne dotyczące dawek przy których mogą występować objawy uboczne nie są jednoznaczne. W badaniu populacji chińskiej wykazano, że zwiększona częstość selenozy wiąże się ze stosowaniem dawek tego mikroelementu powyżej 850 µg/dobę [26] . Z kolei, u pacjentów z reumatoidalnym zapaleniem stawów dzienna podaż 600 µg selenu uzyskanego z drożdży przyczyniła się do zmniejszenia nasilenia bólu stawów, przy braku objawów zatrucia selenem [39] . W innym badaniu pacjenci otrzymujący około 700 µg selenu dziennie dobrze tolerowali tę dawkę [40] . Zdaniem wielu autorów największe korzyści z suplementacji selenem odnoszą osoby, u których podaż tego pierwiastka jest obniżona. W innych przypadkach należy brać pod uwagę zwiększone ryzyko wystąpienia zaburzeń metabolicznych [38, 41] .
Jak działa selen?
Jak już wcześniej wspomniano, atomy selenu wchodzą w skład tak zwanych selenoprotein oraz enzymów antyoksydacyjnych, między innymi: PG, tioredoksynoreduktaz (TRR), dejodynaz jodotyroninowych (DJ), SPP1 i selenoproteiny W. Peroksydaza glutationu była pierwszą opisaną selenoproteiną, jednak do tej pory zidentyfikowano 8 izoform tego enzymu, różniących się budową i miejscem występowania [42] . Głównym zadaniem PG jest ochrona błon lipidowych przed stresem oksydacyjnym. Katalizują one reakcje redukcji nadtlenku wodoru (H 2 O 2 ) oraz nadtlenków organicznych (ROOH), z wytworzeniem kwasu selenawego jako półproduktu lub odpowiednich alkoholi [33] .
Wyróżnia się trzy typy dejodynaz jodotyroninowych. Pełnią one kluczową rolę w aktywacji pozostałych form HT do najbardziej aktywnej trijodotyroniny (T3) (typ 1 i 2), a ponadto w inaktywacji tyroksyny i T3 (typ 3) [43] [44] [45] [46] . Wyżej wymieniona grupa enzymów pełni zatem kluczową rolę we właściwym funkcjonowaniu tarczycy, a także jej rozwoju [47] . W sytuacji niedoboru selenu upośledzeniu ulega metabolizm jodu, co przyczynia się do zaburzeń syntezy HT, a to może mieć przełożenie na stan kliniczny i samopoczucie pacjentów [34] .
Tioredoksynoreduktazy pod względem biochemicznym odpowiadają za reakcję redukcji utlenionej tioredoksyny. Enzymy tej grupy stanowią dawcę elektronu dla innych ważnych enzymów oksydoredukcyjnych, np. reduktazy rybonukleotydowej i peroksydazy tioredoksyny. Same tioredoksyny wykazują właści-wości inhibitorów apoptozy, czynników wzrostu oraz reduktorów hydroperoksydazy. Dodatkowo reduktaza tioredoksyny może redukować utleniony glutation, kwas dehydroaskorbinowy, witaminę K, nadtlenki lipidów oraz nadtlenek wodoru [48] . Selenoproteina P1 oprócz roli magazynu i transportera selenu w organizmie pełni także rolę chelatora metali ciężkich, poprzez tworzenie z nimi nietoksycznych kompleksów oraz może wywierać działanie przeciwnowotworowe [49, 50] . Selenoproteina W odpowiada za metabolizm układu mięśniowego, a N za rozwój mięśni [3, 51] . Wykazano, że określone mutacje genu dla selenoproteiny N, mogą powodować miopatię multiminicore [51] . Zidentyfikowano również inne selenoproteiny S, M [47, 52, 53], jednakże ich rola nie została jeszcze dokładnie poznana.
Wspomniano już wcześniej, że selen może regulować funkcjonowanie układu immunologicznego [1, 2] . Wykazano, że wyżej wymieniony pierwiastek może stymulować syntezę przeciwciał, zwłaszcza IgG i IgM oraz aktywować limfocyty T i makrofagi [38] . Udowodniono także, że związki zawierające selen mogą hamować transformację zakażenia wirusem HIV do pełnoobjawowego AIDS [54] . Selen wywiera także właściwości przeciwwirusowe i antybakteryjne oraz hamuje progresję różnych postaci wirusowego zapalenia wątroby, a nawet może zapobiegać infekcji niektórymi RNA wirusami, między innymi wirusem Ebola [1, 2, 55, 56] .
Postulowane właściwości przeciwnowotworowe selenu, w dużej mierze opierają się na jego wspomnianych już właściwościach antyoksydacyjnych. Warto także wspomnieć o jego korzystnym wpływie na aktywację limfocytów NK [50] . Do tej pory opisano jego pozytywne właściwości w kontekście raka jelita grubego, gruczołu krokowego oraz płuc [52] . Pojawiły się także doniesienia na temat roli selenu w przewodnictwie impulsów w ośrodkowym układzie nerwowym (OUN) [1, 57] . Ponadto, wspomniany mikroelement może zapobiegać cukrzycy, chorobom układu krążenia i niepłodności [26, 32] .
Selen a gruczoł tarczowy
Choroby tarczycy uważane są za jedne z częstszych ogółem i zdecydowanie najczęstsze problemy natury endokrynologicznej, z jakimi pacjenci zgłaszają się do lekarza [58] [59] [60] . Z kolei L-tyroksyna znajduje się w pierwszej dziesiątce powszechnie przyjmowanych i najczęściej przepisywanych leków [58, 61] .
